CEN Biotech Inc (CENBF)
0.0033
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
CEN Biotech Cash from Investing (Quarterly): -0.0496M for March 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -0.0496M |
| December 31, 2022 | 0.0099M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | -0.0568M |
| September 30, 2021 | 0.1867M |
| June 30, 2021 | -0.17M |
| March 31, 2021 | 0.05M |
| December 31, 2020 | -0.0269M |
| September 30, 2020 | -0.1032M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.03M |
| September 30, 2019 | -0.04M |
| June 30, 2019 | -0.09M |
| March 31, 2019 | -0.03M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.10M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.0054M |
| December 31, 2017 | -0.0184M |
| September 30, 2017 | -0.1397M |
| June 30, 2017 | -0.044M |
| March 31, 2017 | -0.3087M |
| December 31, 2016 | -0.1302M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | -0.3029M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | -0.00 |
| March 31, 2015 | -0.0477M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.17M
Minimum
Jun 2021
0.1867M
Maximum
Sep 2021
-0.02M
Average
-0.0135M
Median
Cash from Investing (Quarterly) Benchmarks
| Rimrock Gold Corp | -0.0057M |
| InMed Pharmaceuticals Inc | -0.0093M |
| Venus Concept Inc | -0.027M |
| Juva Life Inc | -0.3611M |
| Lucy Scientific Discovery Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.1023M |
| Free Cash Flow | -0.2248M |
| Free Cash Flow Per Share (Quarterly) | 0.0008 |
| Free Cash Flow to Equity (Quarterly) | 0.0833M |
| Free Cash Flow to Firm (Quarterly) | 0.0902M |